Date & time: Fri, January 17, 2025 | 09:00 - 12:30
Venue: Riyadh International Convention and Exhibition Center
Indications & decision for switching to systemic therapy in Oral Medicine (case-based discussion)
This half-day workshop is designed for oral healthcare professionals involved in the management of orofacial lesions/conditions. The workshop aims to enhance participants’ understanding of when and how to transition from topical to systemic therapy in challenging cases. Attendees will be divided into two groups, each guided by an expert facilitator, to engage in round table discussions. Through the analysis of complex clinical cases, previously treated with topical therapy, participants will develop a deeper insight into the decision-making process for systemic therapy initiation. The interactive format encourages collaborative learning and critical thinking, equipping participants with practical skills for their clinical practice.
Course Objectives:
- Identify key clinical indicators & patient factors that necessitate the transition from topical to systemic therapy.
- Make informed & timely decisions regarding the initiation of systemic therapy considering evidencebased guidelines and contemporary research recommendations.
- Be aware of the systemic therapy side effects & the precautionary measure that should be taken into consideration.
Course Program:
| TIME | TOPICS |
| 09:00 – 09:30 | Introduction |
| 09.30-11.30 | Round Table Discussion (90 minutes)
Groups A, B, C will rotate through 3 tables, each group will spend 30 minute |
| 11.30-12.30 | Wrap-Up, Reflection, and socialization (15 minutes) |
Workshop fees:
| Early Bird (Til 15 December 2024) |
Onsite (16 December 2024 – 18 January 2025) |
||
| Student | Board Resident/ Dentist | Student | Board Resident / Dentist |
| 100 | 300 | 500 | 700 |
*Prices in SAR
Limited seats only
Speakers:
Dr. Nathaniel Simon Treister
DMD, DMSc
Bio:
Dr. Treister is Chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital and Clinical Director of Oral Medicine and Oral Oncology at the Dana-Farber/Brigham and Women’s Cancer Center in Boston, Massachusetts. Dr. Treister earned his DMD from the University Of Pennsylvania School Of Dental Medicine and subsequently completed his Oral Medicine and Oral Biology training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity. He is board certified in Oral Medicine and practices at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston Children’s Hospital, and Dartmouth-Hitchcock Medical Center, with special interest in oral mucosal diseases.
Dr. Vidya Sankar
DMD, MHS, RCSEd
Bio:
Dr. Sankar received her DMD, completed a GPR, and served as Staff Dentist in the Infectious Disease Clinic from Rutgers School of Dental Medicine. She practiced general dentistry in New Jersey prior to earning her Certificate in Oral Medicine from the National Institute of Dental and Craniofacial Research. She was a recipient of the Sjögren’s Foundation Fellowship, received her Master’s in Health Science degree from Duke University and is certified by the American Board of Oral Medicine (ABOM) and the Royal College of Surgeons of Edinburgh.
Dr. Sankar’s is an Associate Professor, Division Director for Oral Medicine, and Program Director for the TUSDM Oral Medicine Residency at Tufts University School of Dental Medicine. Previous positions include Oral Medicine Clinical Director with tenure at UTHSC San Antonio, Clinic Director Brigham and Women’s Hospital Oral Medicine and Dentistry clinic, Co-Director of the Oral Medicine and Oncology clinic at Dana Farber Cancer Institute. She currently Immediate Past-President of the American Academy of Oral Medicine and she serves as Board member and Treasurer for the Sjogren’s Foundation.
Prof. Nikolaos Nikitakis
MD, DDS, PhD
Bio:
Professor Nikolaos G. Nikitakis received his DDS and MD from the National and Kapodistrian University of Athens (NKUA), Greece and his PhD from the University of Maryland, Baltimore (UMB), USA. He is Diplomate of the ABOMP and Fellow of the AAOMP and AAOM. He has also completed a sabbatical in the School of Dentistry and MD Anderson Cancer Center in the University of Texas, Houston (UTH), USA.
Prof. Nikitakis is currently the Dean, as well as Professor and Chair, Department of Oral Medicine & Pathology and Hospital Dentistry, in the School of Dentistry, NKUA.
He has published over 275 peer-reviewed scientific papers and 200 abstracts, with approximately 3.800 citations and h index: 36 on Scopus and 6.300 citations and h index: 46 on Google Scholar. He is author of a textbook in Contemporary Oral Medicine and Pathology and of several chapters in other textbooks and handbooks. He serves in the Editorial Board of various scientific journals.
SOLD OUT
Sponsored by:
